Rafe McBride

Rafe McBride is an experienced professional in the field of quality assurance and regulatory operations, currently serving as Sr. Director of Quality at 4D Molecular Therapeutics since March 2022. Previously, Rafe held the position of Sr. Director of Clinical and Research Quality Assurance at Astellas Gene Therapies from October 2019 to March 2022. A background in consulting was demonstrated while serving as a Consultant at McBride Consulting from July 2018 to September 2019. Prior roles include Sr. Director of Global Quality and Compliance at Medivation and various regulatory operations positions at Schering-Plough, ImClone Systems, BioMarin, and Genentech, Inc. Rafe's educational qualifications include a Master of Science in Civil and Environmental Engineering from Stanford University and a Bachelor of Arts in Biology from Colorado College.